Luteolin can prevent H. pylori adhesion and infection (Sekiguchi et al.2008) and is also identified as ANO1 inhibitors as potential anticancer therapeutic agents for prostate cancer (Seo et al.2017), besides, it is also identified as a potential IFN mimic or adjuvant in new antiviral drugs (Tai et al.2012). The gene discussed is IFNA1; the disease is infection.